GatePass Capital’s Johnson & Johnson JNJ Stock Holding History

GatePass Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Buy	1,067 +46	+5%	+$10.7K	0.1%	163
2026 Q1	$249K	Buy	+1,021	New	+$238K	0.12%	154

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GatePass Capital's JNJ Position: Q2 2026 in Review

GatePass Capital increased its Johnson & Johnson (JNJ) stake by 4.5% in Q2 2026, buying an estimated $10.7K and bringing the position to 1,067 shares worth $271K. The position accounts for 0.1% of the portfolio, ranked #163.

GatePass Capital first reported a position in JNJ in Q1 2026 and has held it in 2 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

GatePass Capital held 1,067 shares of Johnson & Johnson worth $271K as of Q2 2026.
GatePass Capital bought 46 Johnson & Johnson shares in Q2 2026, an estimated $10.7K.
Johnson & Johnson made up 0.1% of GatePass Capital's portfolio in Q2 2026, its #163 holding.
GatePass Capital first reported a position in Johnson & Johnson in Q1 2026 and has held it in 2 quarters since.
4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on GatePass Capital's 13F filing for Q2 2026, filed 30 Jul 2026.